Pyratape P Horse Wormer 40% w/w Oral Paste

Care should be taken to avoid the following practices because they
increase the risk of development of resistence and could ultimately result
in ineffective therapy:

class, over an extended period of time.

misadministeration of the product, or lack of calibration of the
dosing device(if any).
Suspected clinical cases of resistence to anthelmintics should be further
investigated using appropriate tests (e.g. Faecal Egg Count Reduction
Test). Where the results of the test(s) strongly suggest resistance to a
particular anthelminitc, an anthelmintic belonging to another
pharmacological class and having a different mode of action should be
used.
Resistance to pyrantel has been reported in cyathostomes in horses (also
widespread in the USA and Canada). Therefore the use of this product
should be based on local (regional, farm) epidemiological information
about susceptibility of nematodes and recommendations on how to limit
further selection for resistence to anthelmintics.

Special precautions for use in animals
The same syringe should only be used to dose two animals if they are
both healthy and are either running together, or are on the same premises
and in direct contact with each other.
Special precautions to be taken by the person administering the
veterinary medicinal product to animals
Direct contact with the skin should be avoided.
Wash hands and any other parts of the body which comes into contact
with the product after use.
Avoid handling the product if you know you are hypersensitive to pyrantel